RESMED INC (RMD) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $2.09B | +3.0% |
| 2024 | $2.03B | +8.7% |
| 2023 | $1.87B | +20.2% |
| 2022 | $1.55B | +14.4% |
| 2021 | $1.36B | +9.6% |
| 2020 | $1.24B | +11.4% |
| 2019 | $1.11B | +10.7% |
| 2018 | $1.01B | +16.2% |
| 2017 | $864.99M | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $2.09B | +3.0% |
| 2024 | $2.03B | +8.7% |
| 2023 | $1.87B | +20.2% |
| 2022 | $1.55B | +14.4% |
| 2021 | $1.36B | +9.6% |
| 2020 | $1.24B | +11.4% |
| 2019 | $1.11B | +10.7% |
| 2018 | $1.01B | +16.2% |
| 2017 | $864.99M | — |